Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Towers Regulatory News (HTWS)

Share Price Information for Helios Towers (HTWS)

Share Price is delayed by 15 minutes
Get Live Data
212.40    -4.80 (-2.21%)
Bid:
211.60
Ask:
212.00
Spread: 0.40 (0.189%)
Market Cap: £2.17b
HTWS Live PriceLast checked at - London Stock Exchange

Intraday Helios Towers Share Chart

Holding(s) in Company

20 Jun 2024 18:02

RNS Number : 2944T
Helios Towers PLC
20 June 2024
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BJVQC708

 

Issuer Name

HELIOS TOWERS PLC

 

UK or Non-UK Issuer

UK

 

2. Reason for Notification

An acquisition or disposal of voting rights

 

3. Details of person subject to the notification obligation

Name

Newlight Partners LP

 

City of registered office (if applicable)

New York

 

Country of registered office (if applicable)

United States

 

4. Details of the shareholder

 

Name

City of registered office

Country of registered office

 

 

Quantum Strategic Partners Ltd.

 

 

Cayman Islands

 

 

Cayman Islands

5. Date on which the threshold was crossed or reached

19-Jun-2024

6. Date on which Issuer notified

20-Jun-2024

7. Total positions of person(s) subject to the notification obligation

 

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A +

8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

 

13.170000

 

0.000000

 

13.170000

 

138617444

Position of previous

notification (if applicable)

14.990000

0.000000

14.990000

 

 

8. Notified details of the resulting situation on the date on which the threshold

was crossed or reached

 

 

8A. Voting rights attached to shares

 

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

 

 

GB00BJVQC708

 

 

138617444

 

 

13.170000

 

 

 

Sub Total 8.A

 

 

138617444

 

 

13.170000%

 

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

 

 

Type of financial instrument

 

Expiration date

 

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

 

 

Sub

Total 8.B1

 

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

 

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

 

 

Sub

Total 8.B2

9. Information in relation to the person subject to the notification obligation

 

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

 

 

Ultimate controlling person

 

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

 

Ravi Yadav

 

13.170000

 

13.170000%

 

 

Newlight GP LLC

 

 

13.170000

 

 

13.170000%

 

 

Newlight Partners LP

 

 

13.170000

 

 

13.170000%

 

 

David Wassong

 

 

13.170000

 

 

13.170000%

10. In case of proxy voting

Name of the proxy holder

 

 

The number and % of voting rights held

 

 

The date until which the voting rights will be held

 

 

11. Additional Information

 

 

 

12. Date of Completion

20-Jun-2024

 

13. Place Of Completion

New York, NY

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLPPUGUQUPCGMU
Date   Source Headline
19th Mar 202012:08 pmRNSSecond Price Monitoring Extn
19th Mar 202012:02 pmRNSPrice Monitoring Extension
18th Mar 202012:08 pmRNSSecond Price Monitoring Extn
18th Mar 202012:02 pmRNSPrice Monitoring Extension
17th Mar 20204:41 pmRNSSecond Price Monitoring Extn
17th Mar 20204:36 pmRNSPrice Monitoring Extension
17th Mar 202012:07 pmRNSSecond Price Monitoring Extn
17th Mar 202012:02 pmRNSPrice Monitoring Extension
13th Mar 202012:07 pmRNSSecond Price Monitoring Extn
13th Mar 202012:02 pmRNSPrice Monitoring Extension
12th Mar 20209:42 amRNSReplacement: Final Results
12th Mar 20207:00 amRNSFinal Results
11th Mar 202012:02 pmRNSPrice Monitoring Extension
9th Mar 20204:38 pmRNSPrice Monitoring Extension
5th Mar 202012:28 pmRNSDirector Declaration
27th Feb 20204:35 pmRNSPrice Monitoring Extension
27th Feb 202012:07 pmRNSSecond Price Monitoring Extn
27th Feb 202012:02 pmRNSPrice Monitoring Extension
19th Feb 20204:10 pmRNSNotice of Full Year Results Date & Conference Call
7th Feb 202012:02 pmRNSPrice Monitoring Extension
13th Jan 20204:16 pmRNSDirector Declaration
10th Jan 202012:08 pmRNSSecond Price Monitoring Extn
10th Jan 202012:02 pmRNSPrice Monitoring Extension
6th Dec 20194:35 pmRNSPrice Monitoring Extension
3rd Dec 20195:13 pmRNSReduction of Capital
22nd Nov 20199:20 amRNSHolding(s) in Company
21st Nov 20198:53 amRNSHolding(s) in Company
20th Nov 201911:15 amRNSDirector/PDMR Shareholding
20th Nov 201911:13 amRNSDirector/PDMR Shareholding
14th Nov 20197:01 amRNSQ3 2019 Results
14th Nov 20197:00 amRNSQ3 Results for Helios Towers Ltd
13th Nov 201912:51 pmRNSHolding(s) in Company
12th Nov 20197:00 amRNSNotice of Q3 Results Date and Conference Call
8th Nov 20199:56 amRNSHolding(s) in Company
5th Nov 20199:22 amRNSHolding(s) in Company
1st Nov 201912:07 pmRNSSecond Price Monitoring Extn
1st Nov 201912:02 pmRNSPrice Monitoring Extension
31st Oct 20195:01 pmRNSExercise of Over-allotment Option
31st Oct 20197:00 amRNSTotal Voting Rights
23rd Oct 20199:02 amRNSHolding(s) in Company
22nd Oct 20195:10 pmRNSHolding(s) in Company
22nd Oct 20192:59 pmRNSHolding(s) in Company
22nd Oct 20199:40 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSHolding(s) in Company
22nd Oct 20197:00 amRNSHolding(s) in Company
18th Oct 20198:01 amRNSAdmission to Trading on the London Stock Exchange
15th Oct 20192:07 pmRNSApproval and Publication of Prospectus
15th Oct 20197:00 amRNSPre-stabilisation Period Announcement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.